Your browser doesn't support javascript.
loading
Letter to the Editor: Serum identification of At-Risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Noureddin, Mazen; Truong, Emily; Mayo, Rebeca; Martínez-Arranz, Ibon; Mincholé, Itziar; Banales, Jesus M; Arrese, Marco; Cusi, Kenneth; Arias-Loste, María Teresa; Bruha, Radan; Romero-Gómez, Manuel; Iruzubieta, Paula; Aller, Rocio; Ampuero, Javier; Calleja, José Luis; Ibañez-Samaniego, Luis; Aspichueta, Patricia; Marín-Duce, Antonio; Kushner, Tatyana; Ortiz, Pablo; Harrison, Stephen A; Anstee, Quentin M; Crespo, Javier; Mato, José M; Sanyal, Arun J.
Afiliação
  • Noureddin M; Houston Liver Institute, Houston Research Institute, Houston, Texas, United States.
  • Truong E; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States.
  • Mayo R; OWL Metabolomics, Derio, Spain.
  • Martínez-Arranz I; OWL Metabolomics, Derio, Spain.
  • Mincholé I; OWL Metabolomics, Derio, Spain.
  • Banales JM; Biodonostia Research Institute, Donostia University Hospital, University of the Basque Country (UPV-EHU), CIBERehd, IKERBASQUE, Donostia, Spain. Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain.
  • Arrese M; Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Cusi K; University of Florida, Gainesville, Florida, United States.
  • Arias-Loste MT; Marqués de Valdecilla University Hospital, Cantabria University, IDIVAL, Santander, Spain.
  • Bruha R; General University Hospital and the First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Romero-Gómez M; Valme University Hospital, CIBERehd, Seville, Spain.
  • Iruzubieta P; Valme University Hospital, CIBERehd, Seville, Spain.
  • Aller R; Clinic University Hospital, University of Valladolid, Valladolid, Spain.
  • Ampuero J; Virgen del Rocío University Hospital, Sevilla, Spain.
  • Calleja JL; Puerta del Hierro University Hospital, Madrid, Spain.
  • Ibañez-Samaniego L; Gregorio Marañón University Hospital, Madrid, Spain.
  • Aspichueta P; Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, Leioa, Spain. Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Madrid,
  • Marín-Duce A; Príncipe de Asturias University Hospital, Alcalá University, Madrid, Spain.
  • Kushner T; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York City, New York, United States.
  • Ortiz P; Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York City, New York, United States.
  • Harrison SA; Pinnacle Clinical Research, San Antonio, Texas, United States.
  • Anstee QM; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Crespo J; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Madrid, Spain. CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Mato JM; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Instituto de Salud Carlos III), Madrid, Spain. CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Sanyal AJ; Virginia Commonwealth University Medical Center, Richmond, Virginia, United States.
Hepatology ; 2024 Sep 26.
Article em En | MEDLINE | ID: mdl-39325967
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article